Back to results
US 2017/0000883 A1Published application
Superantigen post-exposure therapy
AssigneeThe Secretary of State for Defence
InventorsAlun James CARTER, Sarah Joanne Christine WHITFIELD
Life of this patent
Estimating the term…
Abstract
The present invention relates to a post-exposure therapeutic against superantigen-mediated disease in a subject.
Claims13
A pharmaceutical composition for use in the post-exposure treatment of superantigen (SAg)-mediated disease in a subject, wherein the pharmaceutical composition comprises an active ingredient which is capable of binding an antigen presenting cell B7 receptor.
An agent capable of binding an antigen presenting cell B7 receptor for use in the post-exposure treatment of SAg-mediated disease.
Dependencies are inferred from the claim text.